AzTrials
AzTrials

Cerebral AneurysmNCT03152201

New Findings About Somatosensory Evoked Potentials (SEP) During Surgery for Cerebral Aneurysms

An observational study of Cerebral Aneurysm, run by Luca Valci at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

During surgery, electrophysiological signals will be acquired with the instrument (ISIS IOM, NeuroExplore, Software Version 4.4, Inomed) already in use at the Neurosurgery Service of the Neurocentro of the Hospital Civic Italian Switzerland in Lugano. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Cerebral Aneurysm
What is being tested?
electrophysiological signal
How many people
30 participants
Where
1 siteSwitzerland
Study dates
3 May 2017to 4 Nov 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patient bearer of a not broken cerebral aneurysm

Who may be able to join

  • Age ≥ 18 years old
  • Patient bearer of a not broken cerebral aneurysm, which has been defined per size and morphology susceptible to surgery
  • Aneurysms located on cerebral arteries of the anterior circulation (carotid, middle cerebral arteries, anterior cerebral, anterior communicating, pericallose); Cases of multiple aneurysms are also eligible
  • Informed consent for participation in the study

Who cannot join

  • Patient with an aneurysm of the posterior circulation (vertebrobasilar system)
  • The aneurysm was a source of bleeding (subarachnoid hemorrhage, intracerebral, intraventricular).
  • Patient with a pace-maker (for the risk that the electric currents used in the study could compromise the operation of the pace-maker)

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Neurocentro della Svizzera Italiana (NSI)

    Lugano, 6903

Other trials in Switzerland

About this study

Official title: I Potenziali Somato-sensoriali Nella Chirurgia Degli Aneurismi Cerebrali

During surgery, electrophysiological signals will be acquired with the instrument (ISIS IOM, NeuroExplore, Software Version 4.4, Inomed) already in use at the Neurosurgery Service of the Neurocentro of the Hospital Civic Italian Switzerland in Lugano. Simultaneously to Somatosensorial Evoked Potential (SEP) will also be recorded the Electroencephalography (EEG) activity with the same detection of locations.

For the purposes of the study the signals transmitted to the neurosurgeon through the hardware and the corresponding assessments done by the neurophysiologist responsible for intraoperative monitoring will be recorded. It will also be kept track of procedures performed during surgery.

Being tested
electrophysiological signal
Medical subject headings
Intracranial Aneurysm

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • electrophysiological signalDiagnostic test

    trasmit the electrophysiological signals to the neurosurgeon through the hardware

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. hardware performance

    Collection of information on the hardware performance for reading and interpretation of the SEP and EEG signal and sending an alarm in visual form (light signal) in the eyepiece of the operating microscope during cerebral aneurysm interventions

    Measured: at the moment of the surgery

  2. Identification of sensitive electrophysiological index sensible to cerebral ischemic suffering

    study of the morphology and the analysis of the high frequency of the SEP signal

    Measured: up to 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 May 2017
  2. Study start3 May 2017
  3. Primary completion4 Nov 2021
  4. Study completion4 Nov 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03152201
Sponsor's protocol ID
NCH-2017-01
Status last verified
Aug 2022
First submitted
4 May 2017
Last updated
16 Aug 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Cerebral Aneurysm, run by Luca Valci at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

hardware performance (time frame: at the moment of the surgery). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Aug 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in